Clinical Chemistry · 1993 · 30 citations · 18 references
MedicineBiostatisticsCardiologyClinical CardiologyHealth Data AnalyticsPrecision MedicineCardiac AssessmentCardiac BiomarkersCardiac Enzyme MarkersCardiac Enzyme TestingCreatine Kinase-mbEnzymesReference Interval DeterminationReference Intervals For Enzyme TestsSerum Creatine Kinase AssessmentStatistical Methods For Validation
Changes between serial laboratory test results can be significant, even if none of the individual results exceeds the reference interval. We developed a statistical method for the calculation of reference change limits from routine patients' data for situations in which the majority of the patients can be considered suitable reference subjects. The method was applied to cardiac enzyme data [creatine kinase (CK; EC 2.7.3.2), creatine kinase isoenzyme MB (CK-2), lactate dehydrogenase (LD; EC 1.1.1.28), and lactate dehydrogenase isoenzyme 1 (LD-1)] from 2029 consecutive patients. We used hospital discharge diagnoses to exclude patients with the diagnosis of myocardial infarction or myocarditis, but we also studied the characteristics of the method on unselected patients' data. The reference change limits derived from the diagnosis-selected patient group were as follows (U/L, activity measurements in serum at 37 degrees C according to Scandinavian recommendations): CK from -39 to 27, CK-2 from -8 to 7, LD from -86 to 85, and LD-1 from -19 to 15. Similar limits were obtained by conventional statistical methods from a group of 29 hospitalized patients with no myocardial symptoms. Our results suggest that it is possible to produce clinically applicable reference change limits from routine data.
18
The Prognostic Value of Serum Troponin T in Unstable Angina
Christian W. Hamm, Jan Ravkilde, W. Gerhardt et al. · New England Journal of Medicine · 1992 · 965 citations
Physician and Coding Errors in Patient Records
Susan S. Lloyd · JAMA · 1985 · 264 citations
Health Professions, Health Services Administration, Health Services Research +12